FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Emergent novel SARS-CoV-2 is responsible for the current pandemic outbreak of severe acute respiratory syndrome with high mortality among the symptomatic population worldwide. Given the absence of a current vaccine or specific antiviral treatment, it is urgent to search for FDA-approved drugs that c...
Saved in:
Main Author: | Diaz Sanchez, Angel Gabriel |
---|---|
Other Authors: | Lobo Galo, Naun, Martinez-Martinez, Alejandro, Terrazas-López, Manuel |
Format: | Artículo |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://doi.org/10.1080/07391102.2020.1764393 https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1764393?needAccess=true |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional mining of the crotalus Spp. Venom protease repertoire reveals potential for chronic wound therapeutics
Published: (2020) -
Thyme Essential Oil: Uses, Applications and Extraction
by: Tejada Ortigoza, Viridiana
Published: (2018) -
Desarrollo de Nanopartículas de Quitosano como Vector No Viral para su Posible Aplicación en Terapia Génica
by: Galván Alférez, Tomás Felipe
Published: (2019) -
Milk-clotting enzymes: S.elaeagnifolium as an alternative source
by: Lopez Diaz, Jose Alberto
Published: (2020) -
Síntesis y caracterización de nanopartículas de magnetita cubiertas de ácido poliláctico (M-PLA) y poli-etilenglicol (M-PEG) propuestas como vector no viral en terapia génica
by: Escareño Cruz, Alexia
Published: (2019)